Beneficial ownership — 13D / 13G
85,680 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| ARISTEIA CAPITAL, L.L.C. | WIX Wix.com Ltd. | 13G/A | 0% | Jun 30, 2026 | 3mo |
| North Reef Capital Management LP | ALKT Alkami Technology, Inc. | 13G/A | 8.62% | Jun 30, 2026 | 3mo |
| BAMCO INC /NY/ | CDRO Codere Online Luxembourg, S.A. | 13G/A | 7.74% | Jun 30, 2026 | 3mo |
| BAMCO INC /NY/ | CSGP Costar Group, Inc. | 13G | 5.3% | Jun 30, 2026 | 3mo |
| Flat Footed LLC | DHC Diversified Healthcare Trust | 13G/A | 9.7% | Jun 30, 2026 | 3mo |
| Karpus Management, Inc. | OXLC Oxford Lane Capital Corp. | 13G/A | 3.62% | Jun 30, 2026 | 3mo |
| Lind Global Fund III LP | IVDA Iveda Solutions, Inc. | 13G/A | 9.99% | Jun 30, 2026 | 3mo |
| 1607 Capital Partners, LLC | SDHY PGIM Short Duration High Yield Opportunities Fund | 13G/A | 3.97% | Jun 30, 2026 | 3mo |
| RA CAPITAL MANAGEMENT, L.P. | RANI Rani Therapeutics Holdings, Inc. | 13G/A | 9.9% | Jun 30, 2026 | 3mo |
| Southpoint Capital Advisors LP | FENC Fennec Pharmaceuticals Inc. | 13G/A | 0% | Jun 30, 2026 | 3mo |
| Kenneth Griffin | MED Medifast Inc | 13G/A | 2.6% | Jun 30, 2026 | 3mo |
| Ribbit Capital GP II, Ltd. | WLTH Wealthfront Corp | 13G/A | 4.2% | Jun 30, 2026 | 3mo |
| Fan Yu | WHWK Whitehawk Therapeutics, Inc. | 13G/A | 9.4% | Jun 30, 2026 | 3mo |
| CANADA PENSION PLAN INVESTMENT BOARD | KLRA Kailera Therapeutics, Inc. | 13G | 5.6% | Jun 30, 2026 | 3mo |
| ADAR1 Capital Management, LLC | RACC Research Alliance Corp III | 13G | 8.4% | Jun 30, 2026 | 3mo |
| BAKER BROS. ADVISORS LP | IDYA IDEAYA Biosciences, Inc. | 13G | 5.2% | Jun 30, 2026 | 3mo |
| FULLER & THALER ASSET MANAGEMENT, INC. | GEF Greif, Inc | 13G/A | 4.94% | Jun 30, 2026 | 3mo |
| COATUE MANAGEMENT LLC | FPS Forgent Power Solutions, Inc. | 13G | 7.5% | Jun 30, 2026 | 3mo |
| PERCEPTIVE ADVISORS LLC | IKT Inhibikase Therapeutics, Inc. | 13G/A | 6.9% | Jun 30, 2026 | 3mo |
| TPG GP A, LLC | LFST LifeStance Health Group, Inc. | 13G/A | 25.7% | Jun 30, 2026 | 3mo |
| Karpus Management, Inc. | PECE Peace Acquisition Corp. | 13G | 8.4% | Jun 30, 2026 | 3mo |
| Nut Tree Capital Management, LP | BRSP BrightSpire Capital, Inc. | 13G/A | 1.5% | Jun 30, 2026 | 3mo |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | FWAC Futurewave Acquisition Corp | 13G | 6% | Jun 30, 2026 | 3mo |
| MPM BIOIMPACT LLC | CNTX Context Therapeutics Inc. | 13G/A | 1.4% | Jun 30, 2026 | 3mo |
| ADAR1 Capital Management, LLC | PLRX Pliant Therapeutics, Inc. | 13G | 8.9% | Jun 30, 2026 | 3mo |
| ARISTEIA CAPITAL, L.L.C. | CTAA Clearthink 1 Acquisition Corp. | 13G/A | 7.99% | Jun 30, 2026 | 3mo |
| Venrock Healthcare Capital Partners III, L.P. | APLT Applied Therapeutics, Inc. Common Stock | 13G/A | 0% | Jun 30, 2026 | 3mo |
| Sirenia Capital Management LP | TNXP Tonix Pharmaceuticals Holding Corp. | 13G/A | 4.9% | Jun 30, 2026 | 3mo |
| Portolan Capital Management, LLC | REAX Real REMAX Group Inc. | 13G/A | 5.07% | Jun 30, 2026 | 3mo |
| FULLER & THALER ASSET MANAGEMENT, INC. | MMS Maximus, Inc. | 13G | 5.14% | Jun 30, 2026 | 3mo |
| Alyeska Investment Group, L.P. | GDYN Grid Dynamics Holdings, Inc. | 13G/A | 7.25% | Jun 30, 2026 | 3mo |
| ALLIANCEBERNSTEIN L.P. | CDNL Cardinal Infrastructure Group Inc. | 13G/A | 4.9% | Jun 30, 2026 | 3mo |
| PRICE T ROWE ASSOCIATES INC /MD/ | MEDP Medpace Holdings, Inc. | 13G | 7.2% | Jun 30, 2026 | 3mo |
| Orbis Investment Management Limited | PRAX Praxis Precision Medicines, Inc. | 13G/A | 5.5% | Jun 30, 2026 | 3mo |
| Zimmer Partners, LP | NHP National Healthcare Properties, Inc. | 13G | 6.9% | Jun 30, 2026 | 3mo |
| BRAIDWELL LP | AMAN Amanat Acquisition Corp. | 13G | 9.3% | Jun 30, 2026 | 3mo |
| T. Rowe Price Investment Management, Inc. | DPZ Dominos Pizza Inc | 13G/A | 3.9% | Jun 30, 2026 | 3mo |
| STEMPOINT CAPITAL LP | SRZN Surrozen, Inc. | 13G | 5% | Jun 30, 2026 | 3mo |
| Fourthstone LLC | FXNC First National Corp | 13G/A | 0% | Jun 30, 2026 | 3mo |
| WINDACRE PARTNERSHIP LLC | PRM Perimeter Group Inc. | 13G/A | 9.9% | Jun 30, 2026 | 3mo |
| Linden Advisors LP | TDAC Translational Development Acquisition Corp. | 13G/A | 6.7% | Jun 30, 2026 | 3mo |
| AWM Investment Company, Inc. | SPRB Spruce Biosciences, Inc. | 13G | 5.1% | Jun 30, 2026 | 3mo |
| Nantahala Capital Management, LLC | GRCE Grace Therapeutics, Inc. | 13G/A | 6.75% | Jun 30, 2026 | 3mo |
| BAYVIEW ASSET MANAGEMENT, LLC | FRBT Forbright, Inc. | 13G | 6.1% | Jun 30, 2026 | 3mo |
| PRICE T ROWE ASSOCIATES INC /MD/ | SARO StandardAero, Inc. | 13G/A | 13.6% | Jun 30, 2026 | 3mo |
| You Harry L. | GUAC Berto Acquisition Corp. II | 13G | 13.5% | Jun 30, 2026 | 3mo |
| CH4 Natural Solutions Acquisition Sponsor Manager, LLC | MTNE CH4 Natural Solutions Corp | 13G | 25.5% | Jun 30, 2026 | 3mo |
| IES Holdings, Inc. | RNGR Ranger Energy Services, Inc. | 13G/A | 8.8% | Jun 30, 2026 | 3mo |
| METEORA CAPITAL, LLC | AIIR AIR Global PLC | 13G/A | 0% | Jun 30, 2026 | 3mo |
| ARISTEIA CAPITAL, L.L.C. | FXAC FortuneX Acquisition Corp | 13G | 7.55% | Jun 30, 2026 | 3mo |